13F HOLDINGS REPORT
ACUTA CAPITAL PARTNERS, LLC
Quarter ended Q3 2023 · Filed August 14, 2023 · Accession 0001104659-23-090924
Total Value
$147.6M
Positions
35
Other Managers
0
Confidential Omitted
No
Holdings (35)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | APELLIS PHARMACEUTICALS INC | APLS | 297,596 | $27.1M | 18.37% |
| 2 | AADI BIOSCIENCES INC | WHWK | 1,849,402 | $12.6M | 8.57% |
| 3 | TERNS PHARMACEUTICALS INC | TERN | 970,000 | $8.5M | 5.75% |
| 4 | KURA ONCOLOGY INC. COMMON STOCK | KURA | 709,118 | $7.5M | 5.08% |
| 5 | SYNDAX PHARMACEUTICALS INC | SNDX | 299,841 | $6.3M | 4.25% |
| 6 | DISC MEDICINE INC | IRON | 139,500 | $6.2M | 4.20% |
| 7 | VAXCYTE INC | PCVX | 122,166 | $6.1M | 4.13% |
| 8 | ROCKET PHARMACEUTICALS INC | RCKTW | 306,194 | $6.1M | 4.12% |
| 9 | VIRIDIAN THERAPEUTICS INC | VRDN | 224,707 | $5.3M | 3.62% |
| 10 | IVERIC BIO INC | 46583P102 | 131,454 | $5.2M | 3.50% |
| 11 | ARGENX SE | ARGX | 12,568 | $4.9M | 3.32% |
| 12 | PRAXIS PRECISION MEDICINES I | PRAX | 4,250,000 | $4.9M | 3.31% |
| 13 | VENTYX BIOSCIENCES INC | 92332V107 | 147,318 | $4.8M | 3.27% |
| 14 | CYMABAY THERAPEUTICS INC. COMMON STOCK | 23257D103 | 430,000 | $4.7M | 3.19% |
| 15 | CELLDEX THERAPEUTICS INC | CLDX | 122,343 | $4.2M | 2.81% |
| 16 | CLENE INC | CLNN | 4,240,846 | $3.7M | 2.53% |
| 17 | IKENA ONCOLOGY INC | 45175G108 | 558,000 | $3.7M | 2.48% |
| 18 | EYEPOINT PHARMACEUTICALS INC | EYPT | 382,000 | $3.3M | 2.25% |
| 19 | GH RESEARCH PLC | GHRS | 244,828 | $2.9M | 1.97% |
| 20 | IMMUNOVANT INC | IMVT | 141,755 | $2.7M | 1.82% |
| 21 | VERASTEM INC | VSTM | 300,000 | $2.2M | 1.51% |
| 22 | ROIVANT SCIENCES LTD | ROIV | 220,000 | $2.2M | 1.50% |
| 23 | ENLIVEN THERAPEUTICS INC | ELVN | 104,500 | $2.1M | 1.44% |
| 24 | ALKERMES PLC | ALKS | 44,689 | $1.4M | 0.95% |
| 25 | ACLARIS THERAPEUTICS | ACRS | 121,692 | $1.3M | 0.85% |
| 26 | HILLEVAX INC | 43157M102 | 63,078 | $1.1M | 0.73% |
| 27 | MORPHIC HOLDING INC | 61775R105 | 17,500 | $1.0M | 0.68% |
| 28 | ARROWHEAD PHARMACEUTICALS INC | ARWR | 27,500 | $980,650 | 0.66% |
| 29 | OLEMA PHARMACEUTICALS INC | OLMA | 105,814 | $955,500 | 0.65% |
| 30 | BIOMEA FUSION INC | BMEA | 40,000 | $878,000 | 0.59% |
| 31 | DYNE THERAPEUTICS INC | DYN | 73,000 | $821,250 | 0.56% |
| 32 | REZOLUTE INC | RZLT | 373,400 | $739,332 | 0.50% |
| 33 | SAVARA INC | SVRA | 198,139 | $633,054 | 0.43% |
| 34 | KRONOS BIO INC | 50107A104 | 315,000 | $541,800 | 0.37% |
| 35 | NUVATION BIO INC | NUVB | 90,832 | $15,023 | 0.01% |